← Back to Markets

ARTL

Artelo Biosciences Inc · NASDAQ NMS - GLOBAL MARKET · Pharmaceuticals

$7.29+$0.68 (+10.29%)

Prices delayed up to 5 minutes

AC Intelligence

AC Intelligence

AC Intelligence for ARTL is being prepared.

Key Stats

Key Stats

Open

$6.61

Day High

$7.49

Day Low

$6.29

Prev Close

$6.61

Volume

0

Avg Volume

11.0M

Day Change

+$0.68

Change %

+10.29%

Fundamentals

Fundamentals

P/B

1.20

EPS (TTM)

$-39.25

Market Cap

$5M

52-Wk Range

$2.96 — $85.80

Earnings History

Insider Activity

Who Owns This Stock

Who Owns ARTL

Other40.0%6 holders
Dealer / Bank34.1%2 holders
Passive / Index25.8%2 holders

Based on Q4 2025 13F filings + AC behavioral model

10 institutional holders

Top Holders

1.UBS Group AG
$36.6B
2.TWO SIGMA INVESTMENTS, LP
$25.2B
3.Vanguard Group
+104.2%$11.5B
4.Geode Capital Management
$10.9B
5.Vanguard Group
0.0%$5.6B
6.UBS Group AG
$4.3B
7.Geode Capital Management
$3.0B
8.Tower Research Capital LLC (TRC)
$2.3B
9.UBS Group AG
0.0%$101M
10.Virtu Financial LLC
$21M
11.Bank of America Corp
+54.5%$21M
12.UBS Group AG
-94.0%$6M
13.ROTHSCHILD INVESTMENT LLC
0.0%$2M
14.OSAIC HOLDINGS, INC.
$1M
15.CWM, LLC
$0K

Institutional Pressure

Market Regime:Strong Risk-Off (-0.62)
SELLINGBUYING
Neutral
Other(40.0%)
Dealer / Bank(34.1%)
Facilitating
Passive / Index(25.8%)
Holds

26% passive + quality floor won't sell.

Updated daily · Based on Q4 2025 filings + AC behavioral model

Sentiment Signals

Sentiment Signals

Insider ActivityNo insider transactions in last 90 daysSEC Form 4
Analyst Consensus0 buy, 3 hold, 3 sellFinnhub
↑↑Inst. Flows11 increased/new, 1 decreased/exited (13F)AC 13F Analysis

Sources: SEC Form 4, Finnhub, AC 13F Analysis

On AcidCapitalist

Data provided by Finnhub. Prices delayed up to 5 minutes.